Catalyst Wire Dossier Catalyst Wire Dossier

UDENYCA

pegfilgrastim-cbqv · Accord BioPharma, Inc.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for UDENYCA, covering 2018-11-02 to 2023-12-22. Get the full timeline:

Most recent: FDA Approved: UDENYCA — Supplemental Application (Accord BioPharma, Inc.)

See pricing